The estimated Net Worth of David H Mowry is at least $3.8 million dollars as of 11 September 2023. Mr. Mowry owns over 9,500 units of Cutera Inc stock worth over $63,743 and over the last 9 years he sold CUTR stock worth over $580,511. In addition, he makes $3,154,020 as Chief Executive Officer et Director at Cutera Inc.
Sign up
Mr. Mowry CUTR stock SEC Form 4 insiders trading
David has made over 9 trades of the Cutera Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 9,500 units of CUTR stock worth $137,370 on 11 September 2023.
The largest trade he's ever made was selling 14,254 units of Cutera Inc stock on 16 November 2021 worth over $174,612. On average, David trades about 1,135 units every 57 days since 2015. As of 11 September 2023 he still owns at least 92,381 units of Cutera Inc stock.
You can see the complete history of Mr. Mowry stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Mowry biography
David H. Mowry is Chief Executive Officer, Director of the Company. Prior to joining Cutera, from May 2016 to October 2018, Mr. Mowry served as President and Chief Executive Officer, as well as a member of the Board of Directors, of Vyaire Medical, a global leader in the respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring market segments. Prior to his assignment at Vyaire, Mr. Mowry served as Executive Vice President and Chief Operating Officer and member of the Board of Directors of Wright Medical Group N.V., a global medical device company focused on extremities and biologics products, from October 2015 to May 2016, and during this time period he was also a member of the Board of Directors of EndoChoice Holdings, Inc., a company focused on the manufacturing and commercialization of platform technologies relating to the treatment of gastrointestinal conditions. Prior to Mr. Mowry’s assignment at Wright Medical Group, he served as President and Chief Executive Officer and member of the Board of Directors of Tornier N.V. from February 2013 until October 2015, at which time Tornier and Wright Medical Group merged, and prior to that, as Chief Operating Officer of Tornier from 2011 to 2013. Within the spine industry, Mr. Mowry served as Vice President of Operations and Logistics at Zimmer Spine from February 2002 until October 2006. Mr. Mowry has held executive leadership positions over his thirty year medical device career at Covidien plc, ev3, Inc. and Zimmer Spine, Inc. Mr. Mowry is on the board of directors of Alphatec Holdings, Inc., a public medical technology company that designs, develops, and markets products for the surgical treatment of spine disorders. Mr. Mowry received a B.S. degree in Engineering from the United States Military Academy at West Point. Mowry’s qualifications to serve on our Board include his prior education and training, leadership qualities, and his 30 years of medical device industry experience, including 12 years of executive experie
What is the salary of David Mowry?
As the Chief Executive Officer et Director of Cutera Inc, the total compensation of David Mowry at Cutera Inc is $3,154,020. There are no executives at Cutera Inc getting paid more.
How old is David Mowry?
David Mowry is 57, he's been the Chief Executive Officer et Director of Cutera Inc since 2019. There are 5 older and 5 younger executives at Cutera Inc. The oldest executive at Cutera Inc is Timothy O'Shea, 67, who is the Independent Director.
What's David Mowry's mailing address?
David's mailing address filed with the SEC is C/O ALPHATEC SPINE, INC., 1950 CAMINO VIDA ROBLE, CARLSBAD, CA, 92008.
Insiders trading at Cutera Inc
Over the last 21 years, insiders at Cutera Inc have traded over $58,122,420 worth of Cutera Inc stock and bought 1,064,292 units worth $26,108,997 . The most active insiders traders include Kevin P Connors, J Daniel Plants et David A Gollnick. On average, Cutera Inc executives and independent directors trade stock every 22 days with the average trade being worth of $13,243. The most recent stock trade was executed by Michael Karavitis on 14 May 2024, trading 63,603 units of CUTR stock currently worth $165,368.
What does Cutera Inc do?
cutera was established in the san francisco bay area (brisbane) in 1998 by veteran laser and optical engineers. as the pioneer of nd:yag technology, cutera® is the trusted authority in face + body energy-based medical aesthetic technologies that practitioners around-the-world turn to for innovation, sophistication and performance. at cutera, we’re always looking forward; developing new solutions, products and industry-leading services designed around the needs of medical aesthetic community—delivering better results, faster and safer than ever before. cutera’s premium portfolio of products include: xeo®, trusculpt® and excel v™. in 2014, cutera introduced two new exciting additions to their family of premium products: excel hr™ for high-speed, comfortable, hair removal and enlighten™, the industry’s first picosecond + nanosecond + 2 wavelength high-powered laser system. today, our worldwide presence is represented in 40 countries, with direct operations in north america, france, austra
What does Cutera Inc's logo look like?
Complete history of Mr. Mowry stock trades at Alphatec Inc, Cutera Inc et Wright Medical NV
Cutera Inc executives and stock owners
Cutera Inc executives and other stock owners filed with the SEC include:
-
David Mowry,
Chief Executive Officer, Director -
R. Jason Richey,
President -
David H. Mowry,
CEO & Director -
Rohan Seth,
Chief Financial Officer -
Gregory Barrett,
Independent Director -
J. Daniel Plants,
Independent Chairman of the Board -
Timothy O'Shea,
Independent Director -
Joseph Whitters,
Independent Director -
Katherine Zanotti,
Independent Director -
J. Daniel Plants,
Exec. Chairman -
Anne Werdan,
Director - Investor Relations -
Darren Alch,
Vice President, General Counsel, Secretary -
Rohan Seth,
Chief Financial Officer -
Dr. Michael Karavitis,
Exec. VP & Chief Technology Officer -
Jerry P Widman,
Director -
Miguel Pardos,
EVP, International Sales -
James A. Reinstein,
President and CEO -
Clinton Severson,
Director -
David B Apfelberg,
Director -
Larry Laber,
EVP, North America Sales -
Kevin P Connors,
President and CEO -
David A Gollnick,
VP of Research and Development -
Thomas John Liolios,
VP of International -
Keith J Sullivan,
Director -
Nicholas Sheridan Lewin,
Director -
Sandra A. Gardiner,
EVP & Chief Financial Officer -
Elisha W Finney,
Director -
Guy P Nohra,
Director -
Michael J Levernier,
VP of Clinical Development -
Associates Iii Lp Medventure,
10% owner -
Guy Palta California Partne...,
-
Kathleen A Maynor,
VP of Regulary Affairs & QA -
Associates Management Iii C...,
10% owner -
Guy Palta Partnersalta Cali...,
-
Dean Macfarland,
-
Michael W Sasnett,
-
W Mark Lortz,
Director -
Leonard C De Benedictis,
Chief Technology Officer -
White Annette Campbell,
Director -
Robert John Jr Shine,
VP of International -
Ronald J Santilli,
CFO & VP of Finance and Admin. -
John Connors,
VP of North American Sales -
Jeryl L Hilleman,
Director -
Michael Karavitis,
EVP, Chief Technology Officer -
Sheila Hopkins,
Director -
Juliane Park,
Director -
Janet D. Widmann,
Director -
Kevin J Cameron,
Director -
Stuart Drummond,
Interim CFO -
Taylor C. Harris,
Chief Executive Officer -
Jeffrey S Jones,
Chief Operating Officer -
Stephana Eilene Patton,
Chief Legal Officer